Jeffrey Hager

Biography

Since November 2015, Jeff has served as co-founder and Senior Vice President and Head of Biology at IDEAYA Biosciences. Prior to IDEAYA, he was VP of Biology at Seragon Pharmaceuticals, which was acquired by Roche/Genentech for up to $1.7 billion. Previously, Jeff was Senior Director at Aragon Pharmaceuticals, which was acquired by Johnson & Johnson for up to $1 billion. Prior to Aragon, he was Associate Director of Biology at Apoptos, Inc. and Head of Cancer Pharmacology at Kalypsys, Inc. He did graduate studies at both Princeton and University of California at Berkeley, the latter from which he received a PhD in molecular and cell biology.  He was also a postdoctoral fellow and staff scientist at the University of California at San Francisco.

Research Interest

molecular and cell biology.